Intuitive Surgical, Inc. (NEO:ISRG)

Market Cap	235.81B
Revenue (ttm)	12.47B
Net Income (ttm)	3.56B
Shares Out	n/a
EPS (ttm)	9.78
PE Ratio	66.31
Forward PE	55.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,700
Average Volume	11,852
Open	25.73
Previous Close	25.46
Day's Range	25.29 - 25.73
52-Week Range	24.25 - 33.65
Beta	n/a
RSI	40.18
Earnings Date	Jul 15, 2025

About Intra-Cellular Therapies

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1995
• Employees: 15,638
• Stock Exchange: Cboe Canada
• Ticker Symbol: ISRG

Financial Performance

In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.